tirzepatide and retinopathy The popular #diabetes weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Unveiling Tirzepatide's Therapeutic Spectrum: A
Description
These risks need to be considered together as part of an individual patient profile. Real-world data at a global scale A key strength of the study is its scale and approach
The results now often match what people hope for with their weight loss goals
Neither is approved for type 1 diabetes
Clinical Diabetes : A Publication of the American Diabetes Association Solan M
